BridgeBio Pharma, Inc 10-Q for FY2024 Q3
BridgeBio Pharma, Inc. (BBIO)
10-Q
2024-11-12
For: 2024-09-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on November 12, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).
Headline figures
Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.73M
- down 33.2% from $4.09M a year earlier
- Net loss
- $164.25M
- compared with a net loss of $179.49M a year earlier
- Diluted EPS
- -$0.86
- compared with -$1.08 a year earlier